Relamorelin is found to accelerate gastric emptying & reduce vomiting (Study)

Remalorelin was found, in a randomized double-blind, placebo-controlled study, to reduce the frequency and intensity of vomiting, and to accelerate gastric emptying in adult patients with diabetic Gastroparesis. 

You can find the original article here on EndocinologyAdisor.com

You can see the published study results here in  Gastrojournal.org

Relamorelin is under development by Rhythm Pharmaceuticals. 

JIm Sliney Jr, Editor, ThePactBlog